• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Pioneer Floating Rate

Pioneer Floating Rate

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Brain Injury Survivor Gets His Christmas Wish at Southside Hospital

    Brain Injury Survivor Gets His Christmas Wish at Southside Hospital

  2. Alcyone Lifesciences Appoints Michael Rogawski, International Expert in Treatment of Seizures and Epilepsy to its Clinical and Scientific Advisory Board

    Alcyone Lifesciences Appoints Michael Rogawski, International Expert in Treatment of Seizures and Epilepsy to its Clinical and Scientific Advisory Board

  3. Pioneer Investments Declares Monthly Distributions for Closed-End Funds

    Pioneer Investments Declares Monthly Distributions for Closed-End Funds

  4. Jeff Soinski Named New CEO of Avinger

    Jeff Soinski Named New CEO of Avinger

  5. UPDATE: Tony Robbins tells you how to make money like a billionaire

    UPDATE: Tony Robbins tells you how to make money like a billionaire

  6. Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease

    Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease

  7. South Bascom Pediatrics in Los Gatos Joins Stanford Children’s Health Network of Care

    South Bascom Pediatrics in Los Gatos Joins Stanford Children’s Health Network of Care

  8. Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation

    Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation

  9. OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer

    OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer

  10. ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases

    ONO and Gilead Announce Exclusive License Agreement to Develop BTK Inhibitor, ONO-4059, for the Treatment of B-cell Malignancies and Other Diseases

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.